Eloxx Pharmaceuticals Doses First Patients in Phas...
Category : Clinical Trial Update 16 September 2026Trial Begins to Test Exaluren in Nonsense Mutation Alport Syndrome Eloxx Pharmaceuticals has dose...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Olatec Therapeutics Adds Two Clinical Experts to S...
Category : Clinical Trial Update 16 September 2026Caroline Williams-Gray and David Haase Join Olatec's Clinical Leadership Teams Olatec Therape...
Skyhawk Reports 15-Month Phase 1/2 Results for SKY...
Category : Clinical Trial Update 16 September 2026SKY-0515 Shows Changes in Clinical Measures After 15 Months Skyhawk Therapeutics has announced fi...
Lipocine Starts Phase 3 BLOOM Study of Oral Brexan...
Category : Clinical Trial Update 15 September 2026New Phase 3 Study Will Evaluate 48-Hour At-Home Treatment Lipocine Inc. has announced the start o...
Asahi Kasei Starts Phase II Trial of Cresemba in C...
Category : Clinical Trial Update 15 September 2026Study Will Evaluate Isavuconazonium Sulfate in Pediatric Patients Asahi Kasei Therapeutics Corp....
Latest Newsletter Post
-
Skyhawk Reports 15-Month Phase 1/2..
16 September 2026
-
Olatec Therapeutics Adds Two Clinic..
16 September 2026
-
Eloxx Pharmaceuticals Doses First P..
16 September 2026
-
Agomab Reports Positive Phase 1 Res..
15 September 2026
-
Asahi Kasei Starts Phase II Trial o..
15 September 2026
